New lawsuit creates more uncertainty for Novo Nordisk

Novo Nordisk has been met with a number of lawsuits this month, the latest announced this week. But although it happens at a bad time for the hard-tried company, it will not have a material impact on its business, according to one analyst.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Reuters: Kinesere vil købe J&J's diabetesforretning

Amerikanske Johnson & Johnson kan være på vej til at sælge sin forretning for diabetesudstyr for godt 24 mia. kr., efter flere kinesiske aktører ifølge Reuters har vist interesse i at overtage forretningsdelen.

Related articles